Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chepsy Phillip
Clinical Outcome of Allogeneic SCT With a RIC Regimen in Young Adults With AML in CR1; Impact of Prior Consolidation Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pre-Transplant MRD Predicts Outcome Following Reduced-Intensity and Myeloablative Allogeneic Hemopoietic SCT in AML
Bone Marrow Transplantation
Transplantation
Hematology
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients With Hematologic Malignancies: A Monocenter Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Similar Outcomes Between Adolescent/Young Adults and Children With AML Following Allogeneic Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Anthracycline-Based Consolidation May Determine Outcome of Post-Consolidation Immunotherapy in AML
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
No Evidence of Impact of Maraviroc on Outcome After Allogeneic Hematopoietic Stem Cell Transplant With Reduced Intensity Conditioning (RIC)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
Frontiers in Oncology
Cancer Research
Oncology
Impact of Pretransplant Comorbidities on Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Hematopoietic SCT for Patients With High-Risk Myelodysplastic Syndrome and AML
Bone Marrow Transplantation
Transplantation
Hematology
